Home › PARADEEP › Filing
🔔 Get instant alerts when PARADEEP files quarterly results on BSE Start free trial →

Press Release

Filed: 02 Nov 2026, 12:42 IST Exchange: NSE Category: Financial Results — Press Release
Press Release - Q2FY27 - Revenue from operations 7,364 Cr +7% y-y; EBITDA 431 Cr -38% y-y; PAT 122 Cr -64% y-y - H1 FY27 turnover 13,488 Cr +19% y-y; EBITDA 1,173 Cr; EBITDA/ton improved to 5,866 INR vs 5,719 INR in H1 FY26 - Sales volume 1 Mn tons in Q2 and 2 Mn tons in H1 FY27 despite subdued monsoon - Phos Acid expansion (Phase 1) from 500k to 700k MTPA at Paradeep on track; environmental approvals expected soon - Energy efficiency project at Goa completed; energy consumption optimized by 0.3 GCcal/MT of Urea - Global uncertainty expected to continue; focus on integrated supply chain and product mix optimization
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 PARADEEP — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
⚡
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add PARADEEP to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Paradeep Phosphates Limited

Important. The summary above is generated automatically from Paradeep Phosphates Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.